Effect of central obesity on prostate specific antigen measured by computerized tomography: Related markers and prostate volume

Journal of Urology

Volumn 187, Issue 5, 2012, Pages 1589-1593

  Park, Seung Guk ^a   Choi, Ho Chun ^b   Cho, Belong ^b   Kwon, Young Min ^d   Kwon, Hyuk Tae ^c   Park, Jin Ho ^b  

^a Inje University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^d Samyook Medical Center   (South Korea)

Author keywords

body mass index; intra abdominal fat; organ size; prostate; prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ASIAN; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE; SUBCUTANEOUS FAT; TRANSRECTAL ULTRASONOGRAPHY; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; HUMANS; INTRA-ABDOMINAL FAT; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; WAIST CIRCUMFERENCE;

EID: 84862824402     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.12.067     Document Type: Article

References (28)

1. D.V. Makarov, S. Loeb, R.H. Getzenberg Biomarkers for prostate cancer Annu Rev Med 60 2009 139
2. J. Hernandez, I.M. Thompson Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker Cancer 101 2004 894
3. J.K. Parsons, A.V. Sarma, K. McVary Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions J Urol 182 suppl. 2009 S27
4. P.C. Walsh The association of body mass index and prostate-specific antigen in a population-based study J Urol 174 2005 1825
5. J.H. Fowke, L.B. Signorello, S.S. Chang Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men Cancer 107 2006 2361
6. D.M. Werny, T. Thompson, M. Saraiya Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004 Cancer Epidemiol Biomarkers Prev 16 2007 70
7. L.L. Baez, R.J. Hamilton, A.W. Partin Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer JAMA 298 2007 2275
8. A. Rundle, C. Richards, A.I. Neugut Body composition, abdominal fat distribution, and prostate-specific antigen test results Cancer Epidemiol Biomarkers Prev 18 2009 331
9. R.L. Grubb 3rd, A. Black, G. Izmirlian Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Epidemiol Biomarkers Prev 18 2009 748
10. A.V. Sarma, C.A. Jaffe, D. Schottenfeld Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men Urology 59 2002 362
11. J.H. Fowke, S.S. Motley, M.S. Cookson The association between body size, prostate volume and prostate-specific antigen Prostate Cancer Prostatic Dis 10 2007 137
12. S.J. Freedland, E.A. Platz, J.C. Presti Jr Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection J Urol 175 2006 500
13. R.B. Nadler, P.A. Humphrey, D.S. Smith Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels J Urol 154 1995 407
14. J.H. Park, B.L. Cho, H.T. Kwon Effect of body mass index and waist circumference on prostate specific antigen and prostate volume in a generally healthy Korean population J Urol 182 2009 106
15. D. Du Bois, E.F. Du Bois A formula to estimate the approximate surface area if height and weight be known 1916 Nutrition 5 1989 303
16. P. Boer Estimated lean body mass as an index for normalization of body fluid volumes in humans Am J Physiol 247 1984 F632
17. The Asia-Pacific Perspective: Redefining Obesity and its Treatment World Health Organization, International Association for the Study of Obesity and International Obesity Task Force 2000 Health Communications Sydney
18. Y. Matsuzawa, T. Nakamura, M. Takahashi New criteria for 'obesity disease' in Japan Circ J 66 2002 987
19. J.H. Han, H.S. Park, S.M. Kim Visceral adipose tissue as a predictor for metabolic risk factors in the Korean population Diabet Med 25 2008 106
20. A. Briganti, U. Capitanio, N. Suardi Benign prostatic hyperplasia and its aetiologies Eur Urol 8 suppl. 2009 865
21. W. Bushman Etiology, epidemiology, and natural history of benign prostatic hyperplasia Urol Clin North Am 36 2009 403
22. G.S. Prins, K.S. Korach The role of estrogens and estrogen receptors in normal prostate growth and disease Steroids 73 2008 233
23. B. Fibbi, G. Penna, A. Morelli Chronic inflammation in the pathogenesis of benign prostatic hyperplasia Int J Androl 33 2010 475
24. J.H. Fowke, C.E. Matthews PSA and body composition by dual X-ray absorptiometry (DXA) in NHANES Prostate 70 2010 120
25. M.M. Ibrahim Subcutaneous and visceral adipose tissue: structural and functional differences Obes Rev 11 2010 11
26. G.P. Hoke, G.W. McWilliams Epidemiology of benign prostatic hyperplasia and comorbidities in racial and ethnic minority populations Am J Med 121 2008 S3
27. Y.D. Choi, D.R. Kang, C.M. Nam Age-specific prostate-specific antigen reference ranges in Korean men Urology 70 2007 1113
28. D. He, M. Wang, X. Chen Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population Urology 63 2004 722